Search

Laboratorios Farmaceuticos Rovi SA

Closed

SectorHealthcare

59.35 -0.42

Overview

Share price change

24h

Current

Min

59.25

Max

59.8

Key metrics

By Trading Economics

Income

80M

89M

Sales

39M

192M

P/E

Sector Avg

16.367

55.725

EPS

1.466

Dividend yield

1.63

Profit margin

46.582

Employees

2,470

EBITDA

83M

101M

Dividends

By Acuity

Dividend yield

Sector Avg

1.63%

2.25%

Next Earnings

5 lis 2026

Market Stats

By TradingEconomics

Market Cap

256M

3B

Previous open

59.77

Previous close

59.35

News Sentiment

By Acuity

59%

41%

258 / 339 Ranking in Healthcare

Laboratorios Farmaceuticos Rovi SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

25 wrz 2026, 23:51 UTC

News

CDW Corp completed its acquisition of Lovelytics, enhancing its Services and Solutions portfolio, as shares advanced in after-market trading.

25 wrz 2026, 23:51 UTC

News

AbbVie Inc received FDA approval for Juvmo (Tavapadon), a Parkinson's treatment, contributing to a modest rise in shares during after-market trading.

25 wrz 2026, 23:35 UTC

News

DICK'S Sporting Goods faces two class action lawsuits alleging misleading financial statements, contributing to a modest decline in after-market trading.

25 wrz 2026, 23:15 UTC

News

Skyworks Solutions Inc. has extended the expiration date for Qorvo's senior notes exchange offers to October 2, 2026, with shares modestly higher in after-market trading.

25 wrz 2026, 23:05 UTC

News

PepsiCo plans to raise prices on select chips and sodas by late 2026 or early 2027 due to inflation and rising commodity costs, with stock roughly flat in after-market trading.

25 wrz 2026, 23:05 UTC

News

Vicor Corp raised its third-quarter revenue growth outlook to over 20%, doubling its previous forecast, following a new OEM licensing agreement. Shares advanced in after-market trading.

25 wrz 2026, 23:05 UTC

News

Moody's affirmed BJ's Wholesale Club's Ba1 rating and revised its outlook to positive, contributing to the asset's modest rise in after-market hours.

25 wrz 2026, 23:05 UTC

News

Coca-Cola Consolidated Inc appointed Rob Gehring to lead North American operations, effective December 1, as the stock trades lower in after-market hours.

25 wrz 2026, 23:05 UTC

News

Synopsys Inc is higher in after-market trading following HSBC's new price target of $700, citing AI's potential to enhance revenue capabilities.

25 wrz 2026, 23:05 UTC

Event
News

Merck & Co. has withdrawn its Biologics License Application for ifinatamab deruxtecan after the FDA indicated insufficient trial data, with shares trading lower in after-market hours.

25 wrz 2026, 23:05 UTC

News

Monster Beverage shares are modestly lower in after-market trading following CEO Rob Gehring's resignation announcement effective November 30, 2026.

25 wrz 2026, 23:05 UTC

News

McDonald's Corp plans an $8.5 billion menu overhaul to introduce healthier options, with shares edging higher in after-market trading.

25 wrz 2026, 23:01 UTC

News

Kodiak Sciences Inc. shares rose in after-market trading as the company announced topline results from its DAYBREAK Phase 3 study will be released on September 28, 2026.

25 wrz 2026, 23:01 UTC

News

Chevron Corp's shares rose in after-market trading as the company accelerates plans to export gas from Cyprus's Aphrodite field through Egypt's LNG facilities.

25 wrz 2026, 23:01 UTC

News

Marathon Petroleum's stock is higher in after-market hours as the White House reviews a potential diesel export ban that could impact earnings.

25 wrz 2026, 23:01 UTC

News

PayPal shares rose in after-market hours amid speculation of a potential all-stock takeover and Deutsche Bank's price target increase to $55 from $50.

25 wrz 2026, 22:50 UTC

News

S&P Global Ratings downgraded Cable One's credit rating to 'B+' amid increased competition, but the stock has advanced in after-market trading following five consecutive lower sessions.

25 wrz 2026, 22:45 UTC

News

Viatris Inc is seeing a modest increase in after-market trading after filing a lawsuit against Novo Nordisk over its planned generic Wegovy.

25 wrz 2026, 22:15 UTC

News

Fox Factory Holding Corp. completed the $225 million sale of Marucci Sports, reducing leverage and interest expenses, leading to higher shares in after-market hours.

25 wrz 2026, 22:01 UTC

News

S&P Global Ratings upgraded Rithm Capital Corp's credit rating to 'B+' as the firm diversifies revenue, with assets under management rising to $61 billion.

25 wrz 2026, 21:02 UTC

News

The New York Times Company declared a quarterly dividend of $0.23 per share, while the stock traded modestly lower in after-market hours.

25 wrz 2026, 21:01 UTC

News

Best Buy Co., Inc. plans to sell debt securities, contributing to a modest decline in after-market trading, with shares lower since Friday's close.

25 wrz 2026, 20:08 UTC

Social Media
News

Moderna Inc's stock advanced following CEO Stéphane Bancel's comments on focusing on cancer vaccines and recent positive trial results for its melanoma vaccine.

25 wrz 2026, 20:08 UTC

Social Media
News

Apple shares are advancing as Bernstein maintains a Buy rating with a $370 price target, despite lowering EPS estimates for Q1 to $2.87.

25 wrz 2026, 20:08 UTC

News

ON Semiconductor Corp shares are sharply higher, driven by the launch of its Embedded Power Platform and strengthened partnerships in automotive and AI sectors.

25 wrz 2026, 20:08 UTC

News

C3.ai Inc shares declined modestly as options sentiment remained mixed, with a put/call ratio of 0.33 and implied volatility in the lowest 10% of observations.

25 wrz 2026, 20:08 UTC

News

Snowflake Inc. shares are advancing as the company partners with CrowdStrike to integrate its AI-native Falcon platform into the Snowflake Marketplace.

25 wrz 2026, 20:08 UTC

Correlated Moves
News

Box Inc shares fell as the resignation of Chief Accounting Officer Eli Berkovitch may have contributed to the stock's ongoing decline, marking six consecutive days lower.

25 wrz 2026, 20:08 UTC

Social Media
News

Amazon.com Inc. saw moderately bullish options activity, with calls outpacing puts and a put/call ratio of 0.43, amid rising sentiment for October call options.

25 wrz 2026, 20:08 UTC

News

Aflac shares fell today as Japan Post Holdings sold 12.2k shares, contributing to a price move slightly below Thursday's close.

Peer Comparison

Price change

Laboratorios Farmaceuticos Rovi SA Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Sentiment

By Acuity

258 / 339 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.